Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 10
2003 4
2004 5
2005 8
2006 7
2007 6
2008 3
2009 4
2010 6
2011 11
2012 8
2013 3
2014 4
2015 5
2016 10
2017 10
2018 11
2019 13
2020 16
2021 21
2022 16
2023 11
2024 20
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy.
László T, Pinczés LI, Bátai B, Varga L, Timár B, Gulyás A, Tárkányi I, Plander M, Nagy Z, Rajnics P, Egyed M, Molnár Z, Rottek J, Masszi A, Tamáska P, Szász R, Illés Á, Alpár D, Magyari F, Bödör C. László T, et al. Among authors: illes a. J Pathol. 2025 May 15. doi: 10.1002/path.6434. Online ahead of print. J Pathol. 2025. PMID: 40371810
Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).
Kiladjian JJ, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Empson V, Hasselbalch HC, Kralovics R, Gisslinger H; PROUD‐PV Study Group. Kiladjian JJ, et al. Among authors: illes a. Hemasphere. 2025 May 3;9(5):e70137. doi: 10.1002/hem3.70137. eCollection 2025 May. Hemasphere. 2025. PMID: 40322296 Free PMC article. No abstract available.
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
Brown JR, Seymour JF, Jurczak W, Aw A, Wach M, Illes A, Tedeschi A, Owen C, Skarbnik A, Lysak D, Eom KS, Šimkovič M, Pavlovsky MA, Kater AP, Eichhorst B, Miller K, Munugalavadla V, Yu T, de Borja M, Ghia P; AMPLIFY investigators; AMPLIFY Investigators. Brown JR, et al. Among authors: illes a. N Engl J Med. 2025 Feb 20;392(8):748-762. doi: 10.1056/NEJMoa2409804. Epub 2025 Feb 5. N Engl J Med. 2025. PMID: 39976417 Clinical Trial.
200 results